These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2579648)

  • 41. Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy.
    Cheng M; Ahmed M; Xu H; Cheung NK
    Int J Cancer; 2015 Jan; 136(2):476-86. PubMed ID: 24895182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice.
    Cheung NK; Landmeier B; Neely J; Nelson AD; Abramowsky C; Ellery S; Adams RB; Miraldi F
    J Natl Cancer Inst; 1986 Sep; 77(3):739-45. PubMed ID: 3091900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
    Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
    Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity.
    Thurin J; Thurin M; Kimoto Y; Herlyn M; Lubeck MD; Elder DE; Smereczynska M; Karlsson KA; Clark WM; Steplewski Z
    Cancer Res; 1987 Mar; 47(5):1229-33. PubMed ID: 3815333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.
    Riemer AB; Förster-Waldl E; Brämswig KH; Pollak A; Zielinski CC; Pehamberger H; Lode HN; Scheiner O; Jensen-Jarolim E
    Eur J Immunol; 2006 May; 36(5):1267-74. PubMed ID: 16568495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of gangliosides from carp intestinal mucosa.
    Irie T; Watarai S; Kushi Y; Kasama T; Kodama H
    Fish Shellfish Immunol; 2004 Feb; 16(2):117-25. PubMed ID: 15123316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells.
    Barker E; Mueller BM; Handgretinger R; Herter M; Yu AL; Reisfeld RA
    Cancer Res; 1991 Jan; 51(1):144-9. PubMed ID: 1988079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of high-risk neuroblastoma with anti-GD2 antibodies.
    Castel V; Segura V; Cañete A
    Clin Transl Oncol; 2010 Dec; 12(12):788-93. PubMed ID: 21156409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.
    Parsons K; Bernhardt B; Strickland B
    Ann Pharmacother; 2013 Feb; 47(2):210-8. PubMed ID: 23386066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of interactions of neuroblastoma cell lines with extracellular matrix proteins affects their sensitivity to treatment with the anti-GD2 ganglioside antibody 14G2a.
    Horwacik I; Rokita H
    Int J Oncol; 2017 May; 50(5):1899-1914. PubMed ID: 28393238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance.
    Tibbetts R; Yeo KK; Muthugounder S; Lee MH; Jung C; Porras-Corredor T; Sheard MA; Asgharzadeh S
    Cancer Immunol Immunother; 2022 Jan; 71(1):153-164. PubMed ID: 34043024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.
    Zeng Y; Fest S; Kunert R; Katinger H; Pistoia V; Michon J; Lewis G; Ladenstein R; Lode HN
    Mol Immunol; 2005 Jul; 42(11):1311-9. PubMed ID: 15950727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation and characterization of dimeric small immunoproteins specific for neuroblastoma associated antigen GD2.
    Occhino M; Raffaghello L; Burrone O; Gambini C; Pistoia V; Corrias MV; Bestagno M
    Int J Mol Med; 2004 Sep; 14(3):383-8. PubMed ID: 15289889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients.
    Tai T; Cahan LD; Paulson JC; Saxton RE; Irie RF
    J Natl Cancer Inst; 1984 Sep; 73(3):627-33. PubMed ID: 6206271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro photothermal destruction of neuroblastoma cells using carbon nanotubes conjugated with GD2 monoclonal antibody.
    Wang CH; Huang YJ; Chang CW; Hsu WM; Peng CA
    Nanotechnology; 2009 Aug; 20(31):315101. PubMed ID: 19597244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localization of GD2-specific monoclonal antibody 3F8 in human osteosarcoma.
    Heiner JP; Miraldi F; Kallick S; Makley J; Neely J; Smith-Mensah WH; Cheung NK
    Cancer Res; 1987 Oct; 47(20):5377-81. PubMed ID: 3115567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies.
    Cheung NK; Von Hoff DD; Strandjord SE; Coccia PF
    J Clin Oncol; 1986 Mar; 4(3):363-9. PubMed ID: 3081691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient.
    Yamaguchi H; Furukawa K; Fortunato SR; Livingston PO; Lloyd KO; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3333-7. PubMed ID: 2159145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
    Watarai S; Kushi Y; Shigeto R; Misawa N; Eishi Y; Handa S; Yasuda T
    J Biochem; 1995 May; 117(5):1062-9. PubMed ID: 8586620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
    Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
    Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.